Evidence map›Paper›PMID 29209288›Full record

ArticleFrontiers in microbiology2017

Antimicrobial Effects of Sulfonyl Derivative of 2(5

Irshad S Sharafutdinov, Elena Y Trizna, Diana R Baidamshina, Maria N Ryzhikova, Regina R Sibgatullina, Alsu M Khabibrakhmanova, Liliya Z Latypova, Almira R Kurbangalieva, Elvira V Rozhina, Mareike Klinger-Strobel and 5 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 62 citations in OpenAlex.

  1. 3,4-Dihalo-5-hydroxy-2(5Molecules (Basel, Switzerland) · 2024
    Review
  2. RSC advances · 2024
    Article
  3. The Antimicrobial Potential of the Hop (Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  4. Article
  5. Repression ofMicroorganisms · 2023
    Article
  6. The Novel Chiral 2(5Molecules (Basel, Switzerland) · 2023
    Article
  7. Article
  8. Article
  9. ACS omega · 2022
    Article
  10. Multi-Omics Analysis Reveals Anti-International journal of molecular sciences · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Increasing Susceptibility of Drug-ResistantMolecules (Basel, Switzerland) · 2020
    Article
  17. A Novel Peptide Antibiotic Produced byFrontiers in microbiology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Irshad S SharafutdinovInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Elena Y TriznaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Diana R BaidamshinaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Maria N RyzhikovaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Regina R SibgatullinaBiofunctional Chemistry Laboratory, Alexander Butlerov Institute of Chemistry, Kazan Federal University, Kazan, Russia.
Alsu M KhabibrakhmanovaBiofunctional Chemistry Laboratory, Alexander Butlerov Institute of Chemistry, Kazan Federal University, Kazan, Russia.
Liliya Z LatypovaBiofunctional Chemistry Laboratory, Alexander Butlerov Institute of Chemistry, Kazan Federal University, Kazan, Russia.
Almira R KurbangalievaBiofunctional Chemistry Laboratory, Alexander Butlerov Institute of Chemistry, Kazan Federal University, Kazan, Russia.
Elvira V RozhinaInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Mareike Klinger-StrobelCenter for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Rawil F FakhrullinInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Mathias W PletzCenter for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Mikhail I BogachevBiomedical Engineering Research Centre, Saint Petersburg Electrotechnical University, Saint Petersburg, Russia.
Airat R KayumovInstitute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Oliwia MakarewiczCenter for Infectious Diseases and Infection Control, Jena University Hospital, Jena, Germany.
Kazan Federal University · RUJena University Hospital · DESaint Petersburg State Electrotechnical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The gram-positive opportunistic bacterium

Indexed as

2(5H)-furanonesantimicrobials synergismbiofilmMRSAStaphylococcus aureussulfones

Identifiers

PMID29209288
PMCPMC5701942
OpenAlexW2771037435

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.